BRCA2 and breast carcinoma: In this study we have also identified 19 BRCA1 and 3 BRCA2 VUS (Table 2) that were predicted to alter known in vitro and in vivo phosphorylated sites, however, not yet characterized for their biological role in protein function or in breast cancer development.